uz
Feedback
๐—”๐—ฅ๐—ข๐—ก ๐—ฆ๐—ง๐—จ๐——๐—ฌ

๐—”๐—ฅ๐—ข๐—ก ๐—ฆ๐—ง๐—จ๐——๐—ฌ

Kanalga Telegramโ€™da oโ€˜tish

ุจุณู… ุงู„ู„ู‡ ุงู„ุฑุญู…ู† ุงู„ุฑุญูŠู… ุงู„ู„ู‡ู… ุตู„ ุนู„ู‰ ู…ุญู…ุฏ ูˆุขู„ ู…ุญู…ุฏ ู…ุญุชูˆู‰ ุงู„ู‚ู†ุงุฉ: ุดุฑูˆุญุงุช ุตูŠุฏู„ุฉ ุนุถูˆูŠุฉ ู…ุฑุญู„ุฉ ุซุงู†ูŠุฉ ูƒูˆุฑุณ ุซุงู†ูŠ ูุงุฑู…ุง ู…ุฑุญู„ุฉ ุซุงู„ุซุฉ ูƒูˆุฑุณ ุซุงู†ูŠ ูุงุฑู…ุง ู…ุฑุญู„ุฉ ุฑุงุจุนุฉ ูƒูˆุฑุณ ุงูˆู„ ูุงุฑู…ุง ู…ุฑุญู„ุฉ ุฑุงุจุนุฉ ูƒูˆุฑุณ ุซุงู†ูŠ ุนู„ุงุฌูŠุงุช ู…ุฑุญู„ุฉ ุฎุงู…ุณุฉ ู„ู„ุชูˆุงุตู„: @AronX2bot

Ko'proq ko'rsatish

๐Ÿ“ˆ Telegram kanali ๐—”๐—ฅ๐—ข๐—ก ๐—ฆ๐—ง๐—จ๐——๐—ฌ analitikasi

๐—”๐—ฅ๐—ข๐—ก ๐—ฆ๐—ง๐—จ๐——๐—ฌ (@aronstudy) Arab til segmentidagi kanali faol ishtirokchi. Hozirda hamjamiyat 13 355 obunachidan iborat bo'lib, Tibbiyot toifasida 1 923-o'rinni va Saudiya Arabistoni mintaqasida 5 681-o'rinni egallagan.

๐Ÿ“Š Auditoriya koโ€˜rsatkichlari va dinamika

ะฝะตะฒั–ะดะพะผะพ sanasidan buyon loyiha tez oโ€˜sib, 13 355 obunachiga ega boโ€˜ldi.

27 Iyun, 2026 dagi oxirgi maโ€™lumotlarga koโ€˜ra kanal barqaror faollikka ega. Oxirgi 30 kunda obunachilar soni 213 ga, soโ€˜nggi 24 soatda esa -17 ga oโ€˜zgardi va umumiy qamrov yuqori darajada qolmoqda.

  • Tasdiqlash holati: Tasdiqlanmagan
  • Jalb etish (ER): Auditoriya oโ€˜rtacha 27.63% darajada jalb etiladi. Nashrdan keyingi dastlabki 24 soatda kontent odatda umumiy obunachilar sonining 9.86% ini tashkil etuvchi reaksiyalarni toโ€˜playdi.
  • Post qamrovi: Har bir post oโ€˜rtacha 3 695 marta koโ€˜riladi; birinchi sutkada odatda 1 318 ta koโ€˜rish yigโ€˜iladi.
  • Reaksiyalar va oโ€˜zaro taโ€™sir: Auditoriya faol: har bir postga oโ€˜rtacha 36 ta reaksiya keladi.
  • Tematik yoโ€˜nalishlar: Kontent ู…ูŽุงุฏูŽู‘ุฉ, ุทูŽุงู„ูุจ, ุงูุณุชูุจููŠูŽุงู†, ุณูŽู„ูŽุงู…, ุฑูุณูŽุงู„ูŽุฉ kabi asosiy mavzularga jamlangan.

๐Ÿ“ Tavsif va kontent siyosati

Muallif resursni shaxsiy fikrni ifoda etish maydoni sifatida taโ€™riflaydi:
โ€œุจุณู… ุงู„ู„ู‡ ุงู„ุฑุญู…ู† ุงู„ุฑุญูŠู… ุงู„ู„ู‡ู… ุตู„ ุนู„ู‰ ู…ุญู…ุฏ ูˆุขู„ ู…ุญู…ุฏ ู…ุญุชูˆู‰ ุงู„ู‚ู†ุงุฉ: ุดุฑูˆุญุงุช ุตูŠุฏู„ุฉ ุนุถูˆูŠุฉ ู…ุฑุญู„ุฉ ุซุงู†ูŠุฉ ูƒูˆุฑุณ ุซุงู†ูŠ ูุงุฑู…ุง ู…ุฑุญู„ุฉ ุซุงู„ุซุฉ ูƒูˆุฑุณ ุซุงู†ูŠ ูุงุฑู…ุง ู…ุฑุญู„ุฉ ุฑุงุจุนุฉ ูƒูˆุฑุณ ุงูˆู„ ูุงุฑู…ุง ู…ุฑุญู„ุฉ ุฑุงุจุนุฉ ูƒูˆุฑุณ ุซุงู†ูŠ ุนู„ุงุฌูŠุงุช ู…ุฑุญู„ุฉ ุฎุงู…ุณุฉ ู„ู„ุชูˆุงุตู„: @AronX2botโ€

Yuqori yangilanish chastotasi (oxirgi maโ€™lumot 28 Iyun, 2026 da olingan) sababli kanal doimo dolzarb va katta qamrovli boโ€˜lib qoladi. Analitika auditoriya kontent bilan faol hamkorlik qilishini, uni Tibbiyot toifasidagi muhim taโ€™sir nuqtasiga aylantirishini koโ€˜rsatadi.

13 355
Obunachilar
-1724 soatlar
+3037 kunlar
+21330 kunlar
Postlar arxiv
A 44-year-old woman has been taking fluoxetine 20mg daily for six weeks for Major Depressive Disorder. She reports only minimal improvement in her mood and continues to experience significant fatigue and difficulty concentrating, what would be the MOST appropriate next step in her treatment? A) Changing the dose of fluoxetine. B) Switch to a different antidepressant, such as venlafaxine XR. C) Add bupropion SR to her existing fluoxetine regimen. D) Begin psychotherapy in addition to her medication. E) All of the above are valid therapeutic options 2025 ุฏูˆุฑ 1 ุณุคุงู„ ู…ู…ุชุงุฒ ูˆุงู„ู„ู‡ ูˆู„ูˆ ุงูƒูˆ ุฎู„ู„ ุจูˆุงุญุฏ ู…ู† ุงู„ุงุฎุชูŠุงุฑุงุช ุจุณ ุนุงุฏูŠ ูŠู…ุดูŠ ุญุงู„ ุญุฌูŠุฉ ุนุฏู‡ุง MDD ุงู„ุทุจูŠุจ ู…ู†ุทูŠู‡ุง Fluxetine ู…ุฏุฉ 6 ุงุณุงุจูŠุน ูˆุฑู‡ ู‡ุงู„ูุชุฑุฉ ุงู„ุญุฌูŠุฉ ุชู…ุงู… ุชุญุณู† ู…ุฒุงุฌู‡ุง ุจุณ ุจู‚ุช ุนุฏู‡ุง ุงู„ physical symptom ู…ุณุชู…ุฑุฉ ูŠุนู†ูŠ ุงุณุชุฌุงุจุชู‡ุง ุฌุฒุฆูŠุฉ ุดู†ูˆ ุงู„ุญู„ ุงู„ู…ู†ุงุณุจ ุงู„ูŠ ู…ู…ูƒู† ูŠุณูˆูŠู‡ ุงู„ุฏูƒุชูˆุฑ

R.K is 48 years old man diagnosed to have major depression on antidepressant. The physician checks blood pressure for this patient on cach visit. What do you expect the type of antidepressant used by this patient? A) SSRI B) MAO inhibitor C) TCA D) SNRI E) Serotonin and a2-adrenergic antagonists 2025 ุฏูˆุฑ 1 ุฑุญูŠู… ุงุจู† ุญุฌูŠ ูƒุฑูŠู… ุนู†ุฏู‡ ุงูƒุชุฆุงุจ ูˆุงู„ุทุจูŠุจ ู…ู†ุทูŠู‡ ุนู„ุงุฌ ุจุณ ุดู†ูˆ ูƒู„ู…ุง ูŠุฑุงุฌุน ุงู„ุทุจูŠุจ ุŒุงู„ุทุจูŠุจ ูŠฺ†ูŠูƒ ุถุบุทู‡ ุชุชูˆู‚ุนูˆู† ูŠุง ู…ุฌู…ูˆุนุฉ ู…ู†ุทูŠู‡ุง ุงู„ุทุจูŠุจ ุงู„ู‡ ูˆู„ูŠุด ุฏุงุฆู…ุง ูŠฺ†ูŠูƒ ุงู„ุถุบุทุŸ #MDD

#ุดุฎุงุจูŠุท

ุตูˆุฑ ู…ู…ูƒู† ุชุญุชุงุฌูˆู†ู‡ุง
+5
ุตูˆุฑ ู…ู…ูƒู† ุชุญุชุงุฌูˆู†ู‡ุง

ุงู‡ู†ุฆูƒู… ุจุนูŠุฏ ุงู„ูุทุฑ ุงู„ู…ุจุงุฑูƒ ุงุนุงุฏู‡ ุงู„ู„ู‡ ุนู„ูŠู†ุง ูˆุนู„ูŠูƒู… ุจุงู„ูŠู…ู† ูˆุงู„ุจุฑูƒุงุช ุงุณุฃู„ ุงู† ูŠูˆูู‚ูƒู… ุฌู…ูŠุนุง ููŠ ุงู„ุฃูŠุงู… ุงู„ู‚ุงุฏู…ุฉ ูˆูƒู„ ุนุงู… ูˆุฃู†ุชู… ุจุฃู„ู ุฎ
ุงู‡ู†ุฆูƒู… ุจุนูŠุฏ ุงู„ูุทุฑ ุงู„ู…ุจุงุฑูƒ ุงุนุงุฏู‡ ุงู„ู„ู‡ ุนู„ูŠู†ุง ูˆุนู„ูŠูƒู… ุจุงู„ูŠู…ู† ูˆุงู„ุจุฑูƒุงุช ุงุณุฃู„ ุงู† ูŠูˆูู‚ูƒู… ุฌู…ูŠุนุง ููŠ ุงู„ุฃูŠุงู… ุงู„ู‚ุงุฏู…ุฉ ูˆูƒู„ ุนุงู… ูˆุฃู†ุชู… ุจุฃู„ู ุฎูŠุฑโ™ฅ๏ธ

ุงู„ุณู„ุงู… ุนู„ูŠูƒู… ุดุจุงุจ ุทู„ุจุชูˆุง ู…ู†ูŠ ุนุงู„ุงู‚ู„ ุงูˆุถุญ ุงู„ุดุบู„ุงุช ุงู„ูŠ ูุงู‡ู…ู‡ุง ู…ู† ุงู„ุงุฏูุงู†ุณ ู…ุซู„ ุงู„ ir ูˆู…ุง ุญุจูŠุช ุงุฎู„ูŠ ุงู„ุดุฑุญ ู‡ู†ุง ุจุงู„ู‚ู†ุงุฉ ู„ุงู† ู‡ุงูŠ ุฎุงุตุฉ ุจู…ุงุฏุฉ ูƒุงู…ู„ุฉ ุนู„ุงุฌูŠุงุช ูˆู‡ูŠ ุงู„ุงุณุงุณ ูู‡ุงูŠ ุงู„ู‚ู†ุงุฉ ู„ุจุนุถ ู…ูˆุงุถูŠุน ุงู„ุงุฏูุงู†ุณ ูˆุงุชู…ู†ู‰ ุชููŠุฏูƒู… ุงู„ู…ู„ุงุญุธุงุช ุงู„ูŠ ุงุฏุฒู‡ุง ูˆู„ูˆ ุจุดูƒู„ ุจุณูŠุท https://t.me/advaronx2

ุดุจุงุจ ุจุงู„ู†ุณุจุฉ ู„ู„ุงุฏูุงู†ุณ ู…ู† ุฌู†ุช ุฎุงู…ุณุฉ ุฌู†ุช ู‚ูˆูŠ ุจู…ูˆุถูˆุน ุงู„ู€ ir ูƒู„ุด ูˆุทุจุนุง ู‡ุฐุง ู†ุชูŠุฌุฉ ู„ุดูŠ ุณูˆูŠุชู‡ ุทุจุนุง ู‡ุณู‡ ู…ุง ุงุชุฐูƒุฑ ุดูŠ ู…ู†ู‡ุง๐Ÿ˜ ุงู„ู…ู‡ู… ุจูˆู‚ุชู‡ุง ุจุนุฏ ู…ุง ูู‡ู…ุช ุงู„ุงุณุงุณูŠุงุช ูˆูŠ ุฏูƒุชูˆุฑ ุฑุงูุฏ ุฑุญุช ู†ุฒู„ุช ู…ู„ูุงุช ุจูŠู‡ุง ุฌุงุฑุชุงุช ู‡ูˆุงูŠ ูˆุถู„ูŠุช ุงุญู„ ู„ุญุฏ ู…ุง ุตุฑุช ู…ุชุฃูƒุฏ ุงู†ู‡ ู„ูˆ ูŠุฌูŠ ุงู„ู ุฌุงุฑุช ูˆุจุฃูŠ ุตูŠุบุฉ ุจุงู„ุงู…ุชุญุงู† ุฑุญ ุงุฌุงูˆุจ ุจุดูƒู„ ุตุญูŠุญ ุงู„ูŠ ุงุฑูŠุฏ ุงูƒูˆู„ู‡ ุงู†ู‡ ุญุชู‰ ุชุณูŠุทุฑูˆู† ุนู„ู‰ ู‡ุฐุง ุงู„ู…ูˆุถูˆุน ุฎุตูˆุตุง ู…ูˆุถูˆุน ุงู„ุฌุงุฑุชุงุช ู ุฏุงุฆู…ุง ุทู„ุนูˆุง ุฌุงุฑุชุงุช ู…ู† ูƒูˆูƒู„ ูˆุญู„ูˆู‡ู† ูƒุซุฑุฉ ุงู„ุชู…ุฑูŠู† ุฑุญ ุชุฎู„ูŠ ู‡ุงู„ู…ูˆุถูˆุน ุงุณู‡ู„ ุดูŠ ุจุงู„ุงุฏูุงู†ุณ ู…ุซู„ ู…ุง ุฌู†ุช ุงุดูˆูู‡ ูู‡ุงูŠ ุงู„ู…ู„ูุงุช ุงู„ูŠ ุฑุญ ุงู†ุฒู„ู‡ุง ุงู†ุง ุงุนุชู…ุฏุช ูˆุชู…ุฑู†ุช ุนู„ูŠู‡ุง ุจูˆู‚ุชู‡ุง ุงู† ุดุงุก ุงู„ู„ู‡ ุชููŠุฏูƒู… ุงู„ุงูˆู„ ุจูŠู‡ ุงู„ุชุฑุฏุฏุงุช ูˆุจุนุถ ุงู„ุงุณุงุณูŠุงุช ูˆุฌุงุฑุชุงุช ูˆุงู„ุจู‚ูŠุฉ ุจูŠู‡ู† ุฌุงุฑุชุงุช ุชุฏุฑุจูˆู† ุนู„ูŠู‡ู† ู…ุซู„ ุงู„ุงุณุฆู„ุฉ ุจุงู„ุชุนู„ูŠู‚ุงุช ๐Ÿ‘‡

ุงุฎูˆุงู† ุงู„ู…ุฑุญู„ุฉ ุงู„ุฑุงุจุนุฉ ุจุงู„ู†ุณุจุฉ ู„ุชุฃุดูŠุฑุงุช ุงู„ู…ู„ุงุฒู… ุชู„ูƒูˆู‡ู† ุจ ู‡ุฐุง ุงู„ูˆุณู… #ุชุฃุดูŠุฑุงุช ูˆูƒู„ุดูŠ ุชุญุชุงุฌูˆู† ุจ ุงู„ูุงุฑู…ุง ู…ุซุจุช ุงู„ูƒู… ุจู‡ุงูŠ ุงู„ุฑุณุงู„ุฉ ูˆุงู„ู…ู†ู‡ุฌ ู†ูุณู‡ ูกู ู ูช ูˆู‡ุฐุง ู„ู„ุชุฐูƒูŠุฑ ุฎุงู ุงุญุฏ ู†ุงุณูŠ๐Ÿ‘‡ https://t.me/Aronstudy/4065

Alzheimer disease is a progressive illness. Which Neurotransmitters involved in pathophysiology of Alzheimer disease? A- Acetylcholine B- Serotonin C-Glutamate D- Monoamine oxidase type B E- All are involvedโœ… 2022 ุฏูˆุฑ 1 ู‡ูˆ ุตุญ ู‡ุฐู†ูŠ ุงูƒุซุฑ ุดูŠ ุงู„ ach ูˆ Glutamate ุจุณ ูƒู„ ู‡ุฐู‡ ุงู„ Neurotransmitter ู…ู…ูƒู† ุชุณุงู‡ู… ููŠ ุญุฏูˆุซ ุงู„ุฒู‡ุงูŠู…ุฑ ุงู„ุฏุฑุงุณุงุช ู…ุณุชู…ุฑุฉ ูˆู…ู…ูƒู† ู…ุณุชู‚ุจู„ุง ู†ุดูˆู ุนู„ุงุฌุงุช ุซุงู†ูŠุฉ ุงู‚ูˆู‰ ู…ู† ุงู„ู…ุชูˆูุฑุฉ ุญุงู„ูŠุง ู„ู‡ุฐุง ุงู„ู…ุฑุถ #alzheimer

Mr. Ali, 71, with hypertension, presented with memory loss, financial management difficulties, and disorientation. His reduced social activities and mood swings indicated a cognitive decline. An MMSE score of 22 suggested mild Alzheimer's disease, confirmed by MRI. The following treatments can be used as monotherapy, EXCEPT: a- Donepezil b-Memantineโœ… c-Galantamine d- Rivastigmine e- Aducanumab #alzheimer

Ahmcd is a 65 years old man with severe Alzheimer disease. The suitable cholinesterase inhibitor is a- Rivastigmine b- Galantamine e- Aspirin ๐Ÿ˜’ d-Donepezil โœ… e- Lorazepam ุงู„ูˆุญูŠุฏ ู…ู† ุงุฏูˆูŠุฉ ุงู„ cholinestrase inhibitor ุงู„ูŠ ู…ู…ูƒู† ุงุณุชุฎุฏู…ู‡ ุจุญุงู„ุฉ ุงู„ severe #alzheimer

MRI baseline and ater treatcnt should be reconmended with : a- Rivastigmine b- Donepezil c- Aducanumab โœ… d- Galantamine e- Memuntine 2024 ุฏูˆุฑ 1 ุทุจุนุง ุชุญุณูˆู†ู‡ ุณุคุงู„ ู…ุง ูˆุงุถุญ ุงูˆ ุจูŠู‡ ู†ู‚ุต ุงู„ูˆุญูŠุฏ ู…ู† ุงุฏูˆูŠุฉ ุงู„ุฒู‡ุงูŠู…ุฑ ุงู„ูŠ ู†ุณูˆูŠ ูˆูŠุงู‡ MRI ู‡ูˆ Aducanumab ุจุณุจุจ ุงู„ุขุฑูŠุง ARIA ู…ุซู„ ู…ุง ูƒุชู„ูƒู… ู…ู…ูƒู† ูŠุณุจุจ ู†ุฒูŠู ุตุบูŠุฑ ููŠ ุงู„ุฏู…ุงุบ ุงูˆ edema ูˆุญุงู„ุฉ superficial siderosis ุงู„ูŠ ุงุฑุชูุงุน ู…ุงุฏุฉ ุงู„ hemosiderin ููŠ ุงู„ุงู… ุงู„ุญู†ูˆู† ุงูˆ ุงู„ุฌุงููŠุฉ #alzheimer

A 72-year-old male patient presents to the clinic with his daughter, a known case bf Alzheimer disease. On examination, the patient scores 18 on the Folstein Mini Mental State Examination (MMSE). The patient has a medical history for bradycardia and peptic ulcer. Which of the following is the most appropriate nitial pharmacologic treatment for this patient? 2025 ุฏูˆุฑ 1 A) Memantine monotherapy โœ… B) Aducanumab C) Donepezil D) Vitamin E supplementation E) Gabapentin #alzheimer

Which of the following antidepressants is NOT recommended for managing depression in Alzheimer's Disease? A) Sertraline B) Amitriptyline โœ… C) Citalopram D) Escitalopram E) Fluoxetine 2025 ุฏูˆุฑ 1 ุทุจุนุง ู…ุง ู…ุฐูƒูˆุฑ ู…ุซุงู„ ุนู„ูŠู‡ู† ุจุงู„ู…ู„ุฒู…ุฉ ุจุณ ุงู†ุชู… ุฑุญ ุชุงุฎุฐูˆู†ู‡ ุจู…ุญุงุถุฑุฉ ุงู„ depression ูˆู‡ู…ูŠู†ู‡ ุชุนุฑููˆู†ู‡ ุงูƒูŠุฏ ุงู†ุง ุจุงู„ุดุฑุญ ุฐูƒุฑุช ุงู„ูƒู… ู…ุซุงู„ูŠู†
ุงู„ู…ู‡ู… ุงู„ Tricyclic Antidepressant ู…ู…ู†ูˆุนุฉ ู„ู…ุฑูŠุถ ุงู„ุฒู‡ุงูŠู…ุฑ ู„ูŠุด ู„ุงู† ุนุฏู‡ู… anticholinergic effects ูˆู†ูุณ ุงู„ููƒุฑุฉ ู‡ู… ู‡ุงูŠ ุงู„ุงุฏูˆูŠุฉ ุชู‚ู„ู„ ู…ุณุชูˆู‰ ุงู„ ach ูˆุจุงู„ุชุงู„ูŠ ุชูุงู‚ู… ุญุงู„ุฉ ุงู„ู…ุฑูŠุถ
#alzheimer

What is the risk of abruptly stopping Cholinesterase inhibitors in Alzheimer's patients? A) Worsening cognitive function โœ… B) Increased seizures C) Gastrointestinal complications D) short memory loss E) No significant consequences 2025 ุฏูˆุฑ 1 ุฐูƒุฑุช ุงู„ูƒู… ุจุงู„ู…ุญุงุถุฑุฉ ุงู†ู‡ ู…ุง ูŠุตูŠุฑ ุงู„ู…ุฑูŠุถ ูŠุชุฑูƒ ู‡ุฐู‡ ุงู„ุงุฏูˆูŠุฉ ุจุตูˆุฑุฉ ู…ูุงุฌุฆุฉุŒ ู„ูŠุดุŸ
ู‡ูˆ ุงุตู„ุง ู…ุฑูŠุถ ุงู„ุฒู‡ุงูŠู…ุฑ ุตุงูŠุฑ ุนู†ุฏู‡ Loss of cholinergic neuron ูˆู…ุณุชูˆู‰ ุงู„ ach ูŠูƒูˆู† ู…ู†ุฎูุถ
๏ปฟ ู‡ุงูŠ ุงู„ุงุฏูˆูŠุฉ ุฑุญ ุชุนู…ู„ ุนู„ู‰ ุฒูŠุงุฏุฉ ู…ุณุชูˆู‰ ุงู„ Ach ู…ู† ุฎู„ุงู„ ุชุซุจูŠุท ุนู…ู„ cholinestrase enzyme
๐Ÿ”น ู ุงุฐุง ุชุฑูƒู‡ุง ุจุดูƒู„ ู…ุจุงุดุฑุŒ ุฑุญ ูŠุตูŠุฑ Sudden decline in Ach level ุงู†ุฎูุงุถ ุญุงุฏ ูˆุณุฑูŠุน ุจู…ุณุชูˆู‰ ุงู„ Ach ูˆุจุงู„ุชุงู„ูŠ ุชุชูุงู‚ู… ุนู†ุฏู‡ ุงู„ cognitive symptoms
#alzheimer